1 report

IT IS GUT-SELECTIVE MONOCLONAL ANTIBODY AND HAS SUPERIOR SAFETY PROFILE COMPARED TO ANTI-TNFS.

  • Monoclonal Antibody
  • Italy
  • Northern Europe
  • Pfizer Inc.
  • Remicade group